MIRA Pharmaceuticals, Inc. Common Stock
$0.76
$0.04 (+5.52%)
$0.72Day Range$0.76
Key Statistics
Market Cap
$30.24M
Shares Outstanding
42.0M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Aug 3, 2023
Round Lot
100
Locale
US
Trading Data
Day Open
$0.73
Day High
$0.76
Day Low
$0.72
Volume
136.7K
VWAP
$0.75
Prev Close
$0.72
Transactions
--
Acc. Volume
--
About MIRA Pharmaceuticals, Inc. Common Stock
Mira Pharmaceuticals Inc is a clinical-stage pharmaceutical development company focused on developing novel oral small-molecule therapeutics for neurologic, neuropsychiatric, metabolic, and inflammatory disorders. The company's pipeline includes three product candidates: Ketamir-2, MIRA-55, and SKNY-1, three drug candidates designed to address unmet medical needs across neuropathic and inflammatory pain, central nervous system disorders, and metabolic and behavioral conditions. The company operates as a single operating and reportable segment.
PHARMACEUTICAL PREPARATIONSSIC 28342 employees1200 BRICKELL AVENUE, MIAMI, FL, 33131813-369-5150IPO Aug 3, 2023US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001904286
- Composite FIGI
- BBG01H8XP5F5
- Share Class FIGI
- BBG01H8XP681
- Ticker Root
- MIRA
- SIC Code
- 2834
About MIRA Pharmaceuticals, Inc. Common Stock (MIRA) Stock
MIRA Pharmaceuticals, Inc. Common Stock (MIRA) closed the 2026-09-17 session at $0.76, up 5.52% versus the previous close (+0.04). The stock opened at $0.73 and traded between $0.72 and $0.76 during that session. Session trading volume was 137K shares. The volume-weighted average price (VWAP) is $0.75.
Mira Pharmaceuticals Inc is a clinical-stage pharmaceutical development company focused on developing novel oral small-molecule therapeutics for neurologic, neuropsychiatric, metabolic, and inflammatory disorders. The company's pipeline includes three product candidates: Ketamir-2, MIRA-55, and SKNY-1, three drug candidates designed to address unmet medical needs across neuropathic and inflammatory pain, central nervous system disorders, and metabolic and behavioral conditions. The company operates as a single operating and reportable segment.
MIRA Pharmaceuticals, Inc. Common Stock has a market capitalization of $30.2 million. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. MIRA is listed on the XNAS exchange. The company employs approximately 2 people. MIRA Pharmaceuticals, Inc. Common Stock is headquartered in MIAMI, FL. The recorded listing date is 2023-08-03.
On this page you can find market MIRA stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.